Page 5 - Mark Prausnitz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark prausnitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Prausnitz Today - Breaking & Trending Today

HC Wainwright Comments on Clearside Biomedical, Inc.'s FY2023 Earnings (NASDAQ:CLSD)

Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) – Investment analysts at HC Wainwright lifted their FY2023 earnings per share (EPS) estimates for Clearside Biomedical in a research note issued on Wednesday, April 19th. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings per share of ($0.58) for the year, up from […] ....

Vladimir Zarnitsyn , Danielh White , Mark Prausnitz , Banque Cantonale Vaudoise , Samir Kumar Patel , Jpmorgan Chase Co , Needham Company , Newman Dignan Sheerar Inc , Clearside Biomedical Inc , Clearside Biomedical Company Profile , Balyasny Asset Management , Mackenzie Financial Corp , Clearside Biomedical , Get Rating , Biomedical Trading Down , Asset Management , Financial Corp , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd , Earnings Estimates , Hc Wainwright ,

Clearside Biomedical (NASDAQ:CLSD) Upgraded by StockNews.com to "Hold"

StockNews.com upgraded shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) from a sell rating to a hold rating in a research note released on Thursday morning. A number of other research analysts also recently issued reports on CLSD. JMP Securities dropped their target price on shares of Clearside Biomedical from $7.00 to $6.00 and set […] ....

Danielh White , Mark Prausnitz , Banque Cantonale Vaudoise , Vladimir Zarnitsyn , Samir Kumar Patel , Balyasny Asset Management , Jpmorgan Chase Co , Clearside Biomedical Inc , Needham Company , Mackenzie Financial Corp , Newman Dignan Sheerar Inc , Clearside Biomedical , Get Rating , Moderate Buy , Asset Management , Financial Corp , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd , Stocknews Com ,

Clearside Biomedical's (CLSD) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) in a research note published on Wednesday morning, Benzinga reports. The firm currently has a $6.00 target price on the stock. HC Wainwright also issued estimates for Clearside Biomedical’s FY2023 earnings at ($0.58) EPS, Q1 2024 earnings at ($0.15) EPS, […] ....

United States , Mark Prausnitz , Danielh White , Vladimir Zarnitsyn , Samir Kumar Patel , Needham Company , Clearside Biomedical Inc , Renaissance Technologies , Lincoln National Corp , America Corp , Clearside Biomedical , Get Rating , Moderate Buy , Biomedical Stock Down , Street Corp , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd , Reiterated Rating , Hc Wainwright ,

Clearside Biomedical (NASDAQ:CLSD) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) from a sell rating to a hold rating in a research note published on Thursday. CLSD has been the subject of several other research reports. HC Wainwright reaffirmed a buy rating and issued a $6.00 price target on shares of Clearside Biomedical in a research […] ....

United States , Danielh White , Vladimir Zarnitsyn , Mark Prausnitz , Samir Kumar Patel , Needham Company , Renaissance Technologies , Lincoln National Corp , America Corp , Clearside Biomedical Inc , Clearside Biomedical , Get Rating , Moderate Buy , Street Corp , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd , Stocknews Com ,

Brokerages Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Price Target at $6.00

Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) has earned an average recommendation of “Moderate Buy” from the six analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month price target […] ....

Samir Kumar Patel , Danielh White , Vladimir Zarnitsyn , Georgem Lasezkay , Mark Prausnitz , Clearside Biomedical Inc , Needham Company , Water Island Capital , Jpmorgan Chase Co , Balyasny Asset Management , Clearside Biomedical Company Profile , Mackenzie Financial Corp , Newman Dignan Sheerar Inc , Clearside Biomedical , Get Rating , Biomedical Trading Down , Financial Corp , Asset Management , Integrin Inhibitor , Clearside Biomedical Daily , Nasdaq Clsd ,